Pharmacotherapy of obesity: An update.

Cignarella, Andrea; Busetto, Luca; Vettor, Roberto

Cignarella, Andrea; Busetto, Luca; Vettor, Roberto.

Afiliação

Cignarella A; Department of Medicine, University of Padova Medical School, Via Giustiniani 2, 35128 Padova, Italy. Electronic address: andrea.cignarella@unipd.it.
Busetto L; Center for the Study and the Integrated Management of Obesity, Padova University Hospital, Via Giustiniani 2, 35128 Padova, Italy; Department of Medicine, Internal Medicine 3,University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
Vettor R; Center for the Study and the Integrated Management of Obesity, Padova University Hospital, Via Giustiniani 2, 35128 Padova, Italy; Department of Medicine, Internal Medicine 3,University of Padova, Via Giustiniani 2, 35128 Padova, Italy.

Pharmacol Res ; 169: 105649, 2021 07.

Article em En | MEDLINE | ID: mdl-33962014

Assuntos

Fármacos Antiobesidade/uso terapêutico; Obesidade/tratamento farmacológico; Animais; Depressores do Apetite/uso terapêutico; Humanos

Palavras-chave

Bupropion (PubChem CID: 444); Diabetes; Glucagon receptor family; Individual variation; Liraglutide (PubChem CID: 16134956); Lorcaserin hydrochloride hemihydrate (PubChem CID: 70678853); Naltrexone (PubChem CID: 5360515); Naltrexone/Bupropion (PubChem CID: 11556075); Obesity; Orlistat (PubChem CID: 3034010); Phentermine (PubChem CID: 4771); Phentermine/Topiramate (PubChem CID: 9848354); Setmelanotide (PubChem CID: 11993702); Topiramate (PubChem CID: 5284627); Weight management

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Antiobesidade / Obesidade Limite: Animals / Humans Idioma: En Revista: Pharmacol Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google